newsfilter
← Latest News
GlobeNewswire·

MapLight Therapeutics to Participate in Upcoming Investor Conference

  • MapLight Therapeutics, Inc. (NASDAQ: MPLT) announced management participation in the 2026 Jefferies Global Healthcare Conference.
  • The event is scheduled for Wednesday, November 18, 2026, in London, UK.
  • The company's management team will present at the conference & host one-on-one meetings.
  • Live webcasts & archived recordings of the event will be available on the company's Investor section website at https://ir.maplightrx.com/news-events/events-presentations.
  • MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on treating central nervous system disorders through circuit-specific pharmacotherapies.
  • The company was founded by psychiatry & neuroscience leaders to address the lack of targeted therapies for neural circuits linked to disease.
  • Investor inquiries should be directed to investors@maplightrx.com, while media inquiries should go to media@maplightrx.com.